What better way to celebrate the 10th anniversary of the first meta-GWAS on VTE than with the acceptance of the first meta-GWAS on recurrence?
Molecular Determinants of Thrombosis Recurrence Risk Across Venous Thromboembolism Subtypes.
Munsch G, et al. . Blood. 2025 ahead of print. PMID: 40811855
15.08.2025 19:11 — 👍 0 🔁 0 💬 0 📌 0
New Genomic Discoveries Pave the Way for Research into Predictive thrombosis recurrence Factors and Innovative Preventive Strategies
03.12.2024 19:58 — 👍 0 🔁 0 💬 0 📌 0
First manuscript of my PhD student Blandine Gendre. New molecular player in factor V regulation identified by a underestimated statistical method for GWAS data
10.02.2024 09:32 — 👍 2 🔁 1 💬 0 📌 0
Portfolio of peer-reviewed journals from ASH including Blood, the most cited peer-reviewed publication in hematology, and Blood Advances, Blood Global Hematology, Blood ICT, Blood Neoplasia, Blood RCI, and Blood VTH https://linktr.ee/bloodjournalsportfolio
Nucleic Acids Research (NAR), from Oxford University Press, publishes the results of leading-edge research into physical, chemical, biochemical and biological aspects of nucleic acids and proteins involved in nucleic acid metabolism and/or interactions
Physician-scientist leading a lab @lmumuenchen.bsky.social, visiting scientist
@broadinstitute.org | Writing about genetics, omics, deep phenotyping, precision medicine
https://www.deepvasc.com/
Researcher at @HITh lab InsermU1176 ❤️science, sharing #VWF & #VWD Previously @UniFerrara @UNC
NATA - the network for the advancement of PBM, Haemostasis and Thrombosis. The leading global multidisciplinary medical society that promotes best practices in our field.
Monthly webinars. Annual congress. Bi-weekly literature review.
NATA26🇪🇸30/04-2/05
Cardiologist, genetics researcher.
Massachusetts General Hospital | Harvard Medical School | Broad Institute of Harvard & MIT
Official account for the 14 American Heart Association Journals covering the breadth of cardiovascular & cerebrovascular disease. When you publish in, review for, or read AHA Journals, you join our fight for a world free of cardiovascular disease & stroke.
Executive Director at the International Society on Thrombosis and Haemostasis (ISTH), global association executive and world traveler. Opinions are my own. Retweets do not imply endorsement.
Emeritus Professor of Haemostasis and Thrombosis in Sheffield, UK. I tweet about thrombosis, hemophilia, COVID-19, medicine, NHS & AI. Opinions are my own.
Publishing reviews and commentaries across the fields of genetics and genomics. Part of Springer Nature and Nature Portfolio.
https://www.nature.com/nrg/
La #science pour la #santé
Toute l'actualité de l'Inserm en régions #Bretagne #Paysdelaloire #Centrevaldeloire et au-delà 👨🔬👩🔬🔬🧬🩺
🧬La science pour la santé
L’Institut national de la santé et de la recherche médicale (Inserm) est un établissement public dédié à la recherche biologique, médicale et à la santé humaine.
Notre site internet : https://www.inserm.fr/
Dept. of Internal Medicine, Div. of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands
The ISTH (nonprofit) offers a variety of educational programs & events for those who have a scientific interest in thrombosis, hemostasis & vascular biology.
Professor of Hematology, Lille University, France
The Journal of Thrombosis and Haemostasis (JTH) is the official journal of the ISTH. The mission of JTH is to advance science related to the important medical problems of thrombosis, bleeding disorders and vascular biology. #MedSky #HemeSky #CardioSky
I study thrombosis and vascular biology in sickle cell disease and women’s health @unc.
Professor of hematology/hemostasis at the university of Bordeaux, France.
Work on MyeloProliferative Neoplasms- associated thrombosis and vascular biology.
